Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Statin Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114908129B reveals a novel dehydrogenase mutant for high-purity (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering significant cost and supply chain advantages.
Patent CN112143688A reveals a novel recombinant E. coli strain for high-purity (S)-CHBE production, offering significant cost reduction in API manufacturing.
Novel catalyst-free route for 1-phenyl-5-mercaptotetrazole offering high yield and safety advantages for statin drug manufacturing supply chains.